UnknownNot Applicable

The Youth Initiated Mentoring Approach for Juvenile Delinquents

Netherlands300 participantsStarted 2022-09-13

Plain-language summary

Natural or informal mentorship could potentially be considered effective in preventing or reducing delinquent behaviour. In the Youth Initiated Mentoring (YIM) approach, youths are supported by professionals in identifying and nominating a natural mentor within their own social network. The approach focuses on strengthening these naturally existing relationships with non-parental adults. Until now, little (quasi-)experimental research is conducted on the YIM approach. In the Netherlands, juvenile offenders between 12-18 years are referred to Halt, where they are required to follow a tailored intervention with the aim of preventing reoffending and increasing youths' future opportunities. Since 2019, the YIM approach is implemented as part of the Halt-intervention. The researchers will examine whether the YIM approach is an effective addition to the Halt-intervention. More specifically, whether it contributes to (1) strengthening youths' resilience, (2) decreasing or halting the need for formal support, and (3) decreasing or halting the development of juvenile delinquency. This quasi-experimental trial aims to include 300 youths referred to Halt. Youths will be non-randomly allocated to either a YIM trained Halt professional (N = 31), or a Halt professional not trained in the YIM approach (N = 31). These professionals will implement the Halt-plus-YIM-condition (N =150) or the care-as-usual Halt-condition (N = 150), respectively. Random allocation of youth cases to Halt professionals was not possible because Halt's distribution office considers individuals' workload. Despite non-random allocation, conditions will be comparable in terms of (1) the professionals who deliver the intervention (i.e., same educational level and from the same region), and (2) case type and severity (i.e., allocation is independent of type of offense and its severity as well as the evaluation of number of risk factors present in youth). Researchers will perform a multi-informant measurement strategy. Youths are our primary informants, but parents of youths are also approached to participate. Youth and parent questionnaires related to several youth and family outcomes will be administered at baseline, 100 days after baseline (post-test), and nine months after baseline (follow-up). Researchers will also collect information registered by Halt professionals in Halt's registration system. Read detailed description for more information on outcomes.

Who can participate

Age range

12 Years – 18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * (First) offenders between 12 and 18 years * Referred to Halt by the police, prosecutor, special investigating officer, or a school attendance officer after committing an offense or crime * Three or more meetings with the Halt professional Exclusion Criteria: * In both conditions "shortened cases" (i.e., cases with less than 3 meeting) will be excluded. In both conditions, Halt professionals are instructed to follow their regular working process. In the experimental condition, however, YIM trained professionals will be instructed to motivate and explain the YIM for cases with 3 or more meetings. Because motivation and explanation of the YIM approach are usually performed during a follow-up meeting, it will not be possible to motivate and deploy the YIM approach in shortened cases. Therefore, in both conditions, these cases will be excluded from the study.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Perceived Social Support

Timeframe: Change from baseline at 100 days (post-test)

Social Resourcefulness

Timeframe: Change from baseline at 100 days (post-test)

Trial details

NCT IDNCT05555472

SponsorUniversity of Amsterdam

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-02

Contact for this trial

Angelique Boering, MSc.

+31 (6) 4361176 a.boering@uva.nl

View on ClinicalTrials.gov More Juvenile Delinquency trials